Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.

Metformin Is Associated With Survival Benefit in Cancer Patients With Concurrent Type 2 Diabetes: A Systematic Review and Meta-Analysis

Open access
Yin, Ming, Zhou, Jie, Gorak, Edward J., Quddus, Fahd · 2013 · The Oncologist

Abstract

Learning Objectives: Describe the influences of different types of glucose-lowering medications on therapeutic outcomes of cancer patients who received standard anticancer treatment. Compare the survival associated with metformin treatment with survival in treatment with other glucose-lowering medications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1634/theoncologist.2013-0111

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Research works printed but not linked: 1

  1. Sandulache, 2013, Metformin use is associated with improved survival in patients with laryngeal squamous cell carcinoma, Head Neck

Cited by

See all 157

Metadata

Authors
Yin, M., Zhou, J., Gorak, E. J., & Quddus, F.
Affiliations
  • Department of Internal Medicine, Danville, Pennsylvania, USA
  • Geisinger Medical Center (US)
Corresponding author
  • Yin, Ming
  • Quddus, Fahd
Venue
The Oncologist
Published
2013-11-20
Volume
18
Issue
12
Pages
1248-1255
ISSN
  • 1083-7159 (ISSN-L)
  • 1549-490X
OpenAlex
W2146511561
Cited by
157
References
55
Citations by year
2026: 2 · 2025: 8 · 2024: 5 · 2023: 10 · 2022: 9 · 2021: 15 · 2020: 16 · 2019: 7 · 2018: 11 · 2017: 13 · 2016: 22 · 2015: 22 · 2014: 16 · 2013: 1
FWCI
1.91
Type
journal article
Language
en
Open access
Locations
  • The Oncologist (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
metformin, type 2 diabetes, cancer, overall survival, cancer-specific survival, glucose-lowering medications, cancer mortality, drug repurposing
MeSH terms
Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Metformin, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin Is Associated With Survival Benefit in Cancer Patients With Concurrent Type 2 Diabetes: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1634/theoncologist.2013-0111
The paper
Yin, M., Zhou, J., Gorak, E. J., & Quddus, F. (2013). Metformin Is Associated With Survival Benefit in Cancer Patients With Concurrent Type 2 Diabetes: A Systematic Review and Meta-Analysis. The Oncologist. https://doi.org/10.1634/theoncologist.2013-0111

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.